Exencial Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-831
| Closed | -$465K | – | 390 |
|
|
2020
Q3 | $465K | Buy |
831
+510
| +159% | +$285K | 0.02% | 262 |
|
|
2020
Q2 | $200K | Buy |
+321
| New | +$200K | 0.02% | 314 |
|
|
2020
Q1 | – | Sell |
-905
| Closed | -$340K | – | 267 |
|
|
2019
Q4 | $340K | Hold |
905
| – | – | 0.06% | 198 |
|
|
2019
Q3 | $251K | Hold |
905
| – | – | 0.05% | 215 |
|
|
2019
Q2 | $283K | Hold |
905
| – | – | 0.07% | 186 |
|
|
2019
Q1 | $372K | Hold |
905
| – | – | 0.09% | 165 |
|
|
2018
Q4 | $338K | Buy |
905
+315
| +53% | +$118K | 0.09% | 159 |
|
|
2018
Q3 | $238K | Hold |
590
| – | – | 0.06% | 169 |
|
|
2018
Q2 | $204K | Hold |
590
| – | – | 0.06% | 174 |
|
|
2018
Q1 | $203K | Hold |
590
| – | – | 0.06% | 164 |
|
|
2017
Q4 | $222K | Hold |
590
| – | – | 0.07% | 169 |
|
|
2017
Q3 | $264K | Hold |
590
| – | – | 0.09% | 143 |
|
|
2017
Q2 | $290K | Hold |
590
| – | – | 0.12% | 125 |
|
|
2017
Q1 | $219K | Hold |
590
| – | – | 0.1% | 142 |
|
|
2016
Q4 | $217K | Hold |
590
| – | – | 0.09% | 151 |
|
|
2016
Q3 | $204K | Sell |
590
-25
| -4% | -$8.64K | 0.09% | 156 |
|
|
2016
Q2 | $215K | Sell |
615
-5
| -0.8% | -$1.75K | 0.1% | 145 |
|
|
2016
Q1 | $223K | Buy |
620
+135
| +28% | +$48.6K | 0.11% | 135 |
|
|
2015
Q4 | $233K | Buy |
485
+5
| +1% | +$2.4K | 0.12% | 124 |
|
|
2015
Q3 | $223K | Buy |
+480
| New | +$223K | 0.11% | 128 |
|